BHVNBiohaven Pharmaceutical Holding Company Ltd.
13.85USD-2.05%Mkt Cap: 2.09B $P/E: —3d ago
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which i…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.09B $
Enterprise Value2.07B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-738.82M $
Revenue/Share—
Last Price13.85 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees274
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.79
PEG—
EV/EBITDA-3.98
EV/Revenue—
P/S—
P/B166.67
EPS (TTM)-4.34
EPS (Forward)-1.99
52W Range
7.48057% of range18.57
52W High18.57 USD
52W Low7.480 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-1418.85%
ROA-163.66%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-609.44M $
CapEx (TTM)715.00K $
FCF Margin—
FCF Yield-12.25%
Net Debt29.17M $
Net Debt/EBITDA-0.06
Balance Sheet
Debt/Equity5.47
Current Ratio4.73
Quick Ratio4.28
Book Value/Sh0.0810 USD
Cash/Share1.773 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)23.07 USD
Upside (mean)+66.5%
Target Range10.00 USD – 50.00 USD
$10.00+66.5% to mean$50.00
# Analysts15
Ownership
Shares Out.151.04M
Float116.57M
Insiders11.21%
Institutions95.11%
Short Interest
Short Ratio8.0d
Short % Float15.41%
Short % Out.12.04%
Shares Short18.19M
Short (prev mo.)20.47M
Technical
SMA 5014.40 (-3.8%)
SMA 20011.38 (+21.7%)
Beta3.16
S&P 52W Chg18.16%
Avg Vol (30d)1.73M
Avg Vol (10d)1.97M
Technical Indicators
RSI (14)45.3
MACD0.0072
MACD Signal0.0412
MACD Hist.-0.0340
BB Upper15.10 USD
BB Middle14.16 USD
BB Lower13.22 USD
BB Width13.30%
ATR (14)0.7552 USD
Vol Ratio (20d)1.05x